Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$0.88 - $1.31 $21,086 - $31,390
23,962 New
23,962 $22,000
Q1 2023

May 01, 2023

BUY
$0.68 - $1.11 $14,609 - $23,847
21,484 New
21,484 $15,000
Q3 2022

Nov 07, 2022

BUY
$0.66 - $2.32 $23,719 - $83,378
35,939 New
35,939 $24,000
Q2 2022

Aug 09, 2022

SELL
$1.57 - $3.33 $17,998 - $38,175
-11,464 Closed
0 $0
Q1 2022

May 17, 2022

BUY
$2.76 - $4.64 $31,640 - $53,192
11,464 New
11,464 $37,000
Q4 2021

Feb 17, 2022

SELL
$4.09 - $7.16 $76,515 - $133,949
-18,708 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$5.8 - $8.02 $108,506 - $150,038
18,708 New
18,708 $112,000
Q2 2021

Sep 17, 2021

SELL
$6.87 - $9.16 $105,042 - $140,056
-15,290 Closed
0 $0
Q1 2021

May 19, 2021

BUY
$7.67 - $13.77 $117,274 - $210,543
15,290 New
15,290 $131,000
Q4 2020

Feb 24, 2021

SELL
$12.07 - $17.95 $212,226 - $315,614
-17,583 Closed
0 $0
Q3 2020

Dec 11, 2020

BUY
$14.16 - $19.45 $580 - $797
41 Added 0.23%
17,583 $286,000
Q2 2020

Aug 07, 2020

BUY
$6.97 - $17.12 $122,267 - $300,319
17,542 New
17,542 $263,000
Q3 2019

Nov 20, 2019

SELL
$3.01 - $4.49 $37,164 - $55,438
-12,347 Closed
0 $0
Q2 2019

Aug 13, 2019

SELL
$2.8 - $4.14 $69,442 - $102,676
-24,801 Reduced 66.76%
12,347 $47,000
Q1 2019

Apr 12, 2019

BUY
$2.35 - $4.19 $87,297 - $155,650
37,148 New
37,148 $153,000
Q1 2018

May 14, 2018

SELL
$2.5 - $4.45 $162,310 - $288,911
-64,924 Closed
0 $0
Q4 2017

Feb 09, 2018

BUY
$2.35 - $4.0 $152,571 - $259,696
64,924
64,924 $162,000

Others Institutions Holding CGEN

About COMPUGEN LTD


  • Ticker CGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,624,600
  • Market Cap $152M
  • Description
  • Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...
More about CGEN
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.